Incyte (INCY) Net Margin (2010 - 2026)
Incyte (INCY) reported Net Margin of 34.98% for Q2 2026, up 1.66 percentage points from 33.32% a year earlier and up 11.15 percentage points from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Net Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Incyte's Net Margin came in at 27.71%, up 8.71 percentage points year-over-year; for FY2025, it came in at 25.03%, up 24.26 percentage points from FY2024.
- Net Margin has a five-year change of +36.11 percentage points (FY2020 to FY2025).
- By year, Net Margin came in at 0.77% in FY2024 (-15.40 pp), 16.17% in FY2023 (+6.14 pp), 10.04% in FY2022 (-21.73 pp) and 31.76% in FY2021 (+42.85 pp).
- The Q2 2026 figure ranks as the highest quarterly Net Margin since Q4 2021.
- Year over year, Net Margin has now increased in each of the last five quarters, with an average year-over-year change of +11.82 percentage points over the last eight quarters.
- The high point for year-over-year Net Margin in five years was Q2 2025 (a gain of 75.91 percentage points); the low point was Q2 2024 (a drop of 63.92 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 23.83% (Q1 2026), 19.86% (Q4 2025) and 31.05% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Incyte | 25.09 Bn | 10.02 Bn | 1.57 Bn | 34.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.98% |
| Mar 31, 2026 | 23.83% |
| Dec 31, 2025 | 19.86% |
| Sep 30, 2025 | 31.05% |
| Jun 30, 2025 | 33.32% |
| Mar 31, 2025 | 15.03% |
| Dec 31, 2024 | 17.07% |
| Sep 30, 2024 | 9.36% |
| Jun 30, 2024 | -42.60% |
| Mar 31, 2024 | 19.25% |
| Dec 31, 2023 | 19.84% |
| Sep 30, 2023 | 18.64% |
| Jun 30, 2023 | 21.32% |
| Mar 31, 2023 | 2.68% |
| Dec 31, 2022 | 3.07% |
| Sep 30, 2022 | 13.70% |
| Jun 30, 2022 | 17.71% |
| Mar 31, 2022 | 5.18% |
| Dec 31, 2021 | 65.35% |
| Sep 30, 2021 | 22.35% |
API Access
Incyte Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();